Hillsdale Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-180
Closed -$5.9K 708
2025
Q1
$5.9K Buy
+180
New +$5.9K ﹤0.01% 558